About Sio Gene Therapies
Sio Gene Therapies is a company based in New York (United States) founded in 2014.. The company has 12 employees as of March 31, 2022. Sio Gene Therapies operates in a competitive market with competitors including Tellus Therapeutics and Xenacoronus Healthcare, among others.
- Headquarter New York, United States
- Employees 12 as on 31 Mar, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Axovant Gene Therapies Ltd.
-
Annual Revenue
-
Net Profit
$-221.57 M-22as on Mar 31, 2018
-
EBITDA
$-220.65 M-21as on Mar 31, 2018
-
Latest Funding Round
-
Investors
-
Employee Count
12
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Sio Gene Therapies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Sio Gene Therapies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sio Gene Therapies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sio Gene Therapies Comparisons
Competitors of Sio Gene Therapies
Sio Gene Therapies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tellus Therapeutics and Xenacoronus Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic products for pediatric brain injuries are developed.
|
|
| domain | founded_year | HQ Location |
Develops innovative drugs for treating cardiology, gynecology, and pediatric diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sio Gene Therapies
Frequently Asked Questions about Sio Gene Therapies
When was Sio Gene Therapies founded?
Sio Gene Therapies was founded in 2014.
Where is Sio Gene Therapies located?
Sio Gene Therapies is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Sio Gene Therapies?
Pavan Cheruvu is the current CEO of Sio Gene Therapies.
How many employees does Sio Gene Therapies have?
As of Mar 31, 2022, the latest employee count at Sio Gene Therapies is 12.
What does Sio Gene Therapies do?
Founded in 2014 and headquartered in New York, United States, gene therapies targeting rare neurodegenerative disorders are developed by the company. Focus is placed on AXO-AAV-GM1 for GM1 gangliosidosis and AXO-AAV-GM2 for Tay-Sachs and Sandhoff diseases. These treatments aim to deliver functional enzymes via targeted administration to the thalamus and spinal canal, addressing fatal pediatric conditions through surgical approaches in the biotechnology sector.
Who are the top competitors of Sio Gene Therapies?
Sio Gene Therapies's top competitors include Tellus Therapeutics and Xenacoronus Healthcare.